Navigation Links
Cryolife Victim Responds to Untrue Assertions of Cryolife
Date:1/11/2008

ATLANTA, Jan. 11 /PRNewswire-USNewswire/ -- This morning Michael Hohenbery issued a press release detailing the unsafe practices of Cryolife in the processing of cadaver tissue that was placed inside of his body.

Unfortunately, Cryolife has chosen to issue a press release that contains untrue statements, similar to the untrue press comments they made in the past. See the Federal Court Order of 27 May 2003 in the Cryolife Securities Litigation case where the Federal District Court ruled on the untrue press releases of Cryolife of 7 December 2001, 29 January 2002, 23 April 2002 and 24 June 2002. (In Re Cryolife Inc Securities Litigation, United States District Court, Northern District of Georgia, Atlanta Division, Civil Action No. 1:02-CV-1868-BBM)
In today's press release, Cryolife states:

1. CRYOLIFE: "Shortly after the infection was discovered, Cryolife

notified the FDA of the incident as it was required to do."

THE TRUTH: The clostridium infection sustained by Michael Hohenbery

from the Cryolife cadaver tissue was acknowledged by Cryolife in

writing on February 8, 2007. Cryolife made no effort to notify

other physicians or hospitals who had received tissue from this

cadaver for at least a month and the FDA reflects posting 5 months

later in the Weekly Enforcement Report a Class I recall of certain

cadaver tissue by Cryolife. A class I recall as defined by the FDA

is one in which "there is reasonable probability that the use of or

exposure to the product will cause serious health problems or

death."

2. CRYOLIFE: "Regrettably, the lawyers representing this individual

have chosen to make untrue public statements against our company and

our tissue processing services in an effort to force us into a

monetary settlement of the case."

THE TRUTH: Cryolife was invited to and agreed to attend two

different mediations to attempt to resolve the claims. Cryolife

unilaterally cancelled each of those mediation dates at the last

minute.

Don Keenan is available for comment 24/7. Contact Ben Wilcox 404-523-2200 or bwilcox@keenanlawfirm.com; website http://www.keenanlawfirm.com. The Keenan Building, 148 Nassau Street, NW, Atlanta, GA 30303.


'/>"/>
SOURCE The Keenan Law Firm
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoLife Announces Additions to Management Team
2. Finding the right words: Provider-patient discussions can help domestic violence victims speak up
3. New Automated System Can ID Disaster Victims in Minutes
4. New Automated System IDs Victims of Mass Disasters in Minutes
5. Help is Here Express Bus Tour in California to Help Fire Victims Access Prescription Medicines
6. UNICEF Readies to Assist Mexican Flood Victims
7. Epicel(TM) Wins Marketing Approval for Severe Burn Victims
8. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
9. PepPods Helped Katrina Victims and Now Available to Help California Wildfire Disaster Victims Rebuild Lives with Greater Ease
10. Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims
11. The SCOOTER Store Donates Power Wheelchair to Paraplegic, a Victim of Accidental Shooting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially ... their medication by matching users with high quality water pipes within an ideal price ... commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, who use ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
(Date:6/23/2016)... , ... June 23, 2016 , ... Representatives of CHA ... the newest member of their staff, Dr. Joshua J. Berger. As of May ... of the world-renowned facility. , Dr. Berger has received recognition for his research, his ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology: